2020

• Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

  ATKINSON V. SANDHU S. HOSPERS G. LONG G. V. AGLIETTA M. FERRUCCI P. F. TULYTE S. CAPPELLINI G. C. A. SORIANO V.. ALI S. POPRACH Alexandr CESAS A. RODRIGUEZ-ABREU D. LAU M. DEJONG E. LEGENNE P. STEIN D. KING B. VAN THIENEN J. V.

  Article in Periodical

  MELANOMA RESEARCH, year: 2020, volume: 30, edition: 3, DOI

• Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

  FIALA Ondrej FINEK Jindrich POPRACH Alexandr MELICHAR Bohuslav KOPECKY Jindrich ZEMANOVA Milada KOPECKOVA Katerina MLCOCH Tomas DOLEŽAL Tomáš CAPKOVA Lenka BUCHLER Tomas

  Article in Periodical

  Cancers, year: 2020, volume: 12, edition: 4, DOI

• Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

  BUCHLER Tomas KISS Igor HORNOVA Jana FIALA Ondrej WIESNEROVA Marketa SVOBODA Michal SILAR Jiri KOPECKOVA Katerina POPRACH Alexandr FINEK Jindrich PETRUZELKA Lubos MELICHAR Bohuslav

  Article in Periodical

  Targeted Oncology, year: 2020, volume: 15, edition: 2, DOI

2019

• Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients

  FIALA Ondrej OSTASOV Pavel SOREJS Ondrej LISKA Vaclav BÜCHLER Tomáš POPRACH Alexandr FINEK Jindrich

  Article in Periodical

  Cancers, year: 2019, volume: 11, edition: 12, DOI

• miR-376b and miR-4668 predict therapeutic response to sunitinib in metastatic renal cell carcinoma

  BOHOŠOVÁ Júlia JURÁČEK Jaroslav POPRACH Alexandr BUCHLER T. FIALA O. RADOVÁ Lenka SVOBODA Marek KOPKOVÁ Alena VEČEŘA Marek SLABÝ Ondřej

  Conference abstract

  Year: 2019, type: Conference abstract

• MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients

  BOHOŠOVÁ Júlia JURÁČEK Jaroslav POPRACH Alexandr KOPECKY J. FIALA O. SVOBODA Marek FABIAN Pavel RADOVÁ Lenka BRABEC Petr BUCHLER T. SLABÝ Ondřej

  Article in Periodical

  CANCER GENOMICS & PROTEOMICS, year: 2019, volume: 16, edition: 5, DOI

• miR-376b-3p jako biomarker odpovědi na léčbu sunitinibem u pacientů s metastatickým karcinomem ledviny.

  BOHOŠOVÁ Júlia JURÁČEK Jaroslav POPRACH Alexandr KOPECKÝ J FIALA O SVOBODA Marek FABIAN Pavel RADOVÁ Lenka BUCHLER T SLABÝ O

  Conference abstract

  Year: 2019, type: Conference abstract

• Oligometastatický karcinom prostaty

  NAVRÁTIL Jiří POPRACH Alexandr LAKOMÝ Radek KOCÁK Ivo VAŠINA Jiří KRUPA Pavel VYZULA Rostislav

  Article in Periodical

  Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti., year: 2019, volume: 32, edition: 2

• Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

  BUCHLER Tomas CHLOUPKOVÁ Renata POPRACH Alexandr FIALA Ondrej KISS Igor KOPECKOVA Katerina DUŠEK Ladislav VESKRNOVA Veronika SLAVICEK Lubomir KOHOUTEK Milan FINEK Jindrich SVOBODA Marek PETRUZELKA Lubos MELICHAR Bohuslav

  Article in Periodical

  CANCER MANAGEMENT AND RESEARCH, year: 2019, volume: 11, edition: 2019, DOI

• The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents

  FIALA Ondrej OSTASOV Pavel HOSEK Petr SOREJS Ondrej LISKA Vaclav BUCHLER Tomas POPRACH Alexandr KUCERA Radek TOPOLCAN Ondrej SUSTR Jan SEDIVCOVA Monika FINEK Jindrich

  Article in Periodical

  Anticancer Research, year: 2019, volume: 39, edition: 10, DOI